Attend Dr. Newell’s talk at Samsung Global Research Symposium on T cell Biology

November 7-8, 2019
Samsung Semiconductor, Inc
3655 North First Street, San Jose, CA 95134, USA

Dr. Evan Newell will be presenting a talk on, “Profiling antigen-specific T cells to understand T cell diversity in human health and disease



Visit us at the World Vaccine and Immunotherapy Congress West Coast 2019

December 3-5, 2019
Congress Centre
San Francisco Airport Marriott Waterfront
San Francisco, CA

This conference is dedicated to the vaccine industry with a focus on integrating the technologies revolutionizing immunotherapy and its impact on vaccine development. It brings together senior attendees from the vaccine and immunotherapy industry. 

Click here for more information about the conference.

Click here to view a .pdf of our poster in more detail.


AACR's Tumor Immunology & Immunotherapy Conference

Come see us at AACR’s Tumor Immunology & Immunotherapy Conference 2019

November 17-20, 2019
Boston Marriott Copley Place
Boston, Massachusetts

This AACR Special Conference on Tumor Immunology and Immunotherapy is designed to integrate multidisciplinary facets of basic cancer immunology and immunotherapy to broaden our understanding of ways to harness the immune system to treat cancer.

Click here to learn more about this conference.

Society for Immunotherapy of Cancer

Visit us at SITC 2019

At Gaylord National Hotel & Convention Center, Prince Georges, MD

November 6-10

Talk with one of our scientists at booth 630

Take a look at our latest science at our Posters
(Abstract ID:P75 and P359)

Find out how partnering with us will fast forward your drug discovery and approval pipeline

Stop by our booth to learn if you qualify for a highly discounted pilot program.


Meet immunoSCAPE at ITOC6 in Vienna!

Click here to learn more about this conference.

Keystone Symposia on Molecular and Cellular Biology

Dr Newell and Dr Bonamy to speak at the Keystone Symposia – Cancer Vaccines

Summary of Meeting:
The success of immunotherapy in the treatment of cancer patients has proved the long-standing hypothesis that endogenous adaptive immune responses against the tumor can be harnessed to mediate protection by immune checkpoint blockade. This approach has shown impressive control of disease and improved survival in up to 50% of patients with certain tumors. Genetic and immune analysis of human cancers suggests that one mechanism of resistance to immune checkpoint blockade may be due to lack of tumor-specific T cells. In principle, vaccines have the potential to overcome this defect by either expanding low-level existing tumor-specific T cell responses or priming tumor-specific T cells. Recent advances in next-generation sequencing have improved our understanding of defining cancer antigens. Application of this will require vaccine delivery approaches that can induce potent and broad T cell immunity in an efficient manner for personalized therapy. This Keystone Symposia conference will highlight recent insights in the characterization of immunogenic cancer antigens, the biology and underlying mechanisms of T cell priming, and the development of novel approaches designed to expand T cell responses. Part of the meeting will also be devoted to the development of technologies to monitor T cell responses in response to immune interventions.


Dr. Evan Newell

Dr Newell presentation at the Annual Meeting of the Japanese Society for Immunology

Click here to learn more about this presentation.

immunoSCAPE to present at ESMO Asia 2018

ESMO Asia 2018 will keep oncology professionals in the Asia-Pacific region up to date with the fast pace of oncology science and education, and provide important networking opportunities with international peers.


Society for Immunotherapy of Cancer

Meet immunoSCAPE and see our data at the SITC 2018 Annual Meeting!

As a benefit for attending the 33rd Annual Meeting & Pre-Conference Programs of the Society for Immunotherapy of Cancer (SITC) provides enduring materials free of charge for the specific programs attended. If you are a SITC member, or member of the general public, but did not register to attend a Pre-Conference program or the 33rd Annual Meeting, the materials are now available by clicking the links below.


Meet us at the NeoAg Summit in Boston!

The 4th annual NeoAg Summit is returning to Boston this November to provide your team with one all-inclusive forum to successfully target tumor-specific neoantigens and bring to market personalized cancer vaccines and cellular therapies.